Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
BioCorRxBICX | Open-market buy | 24/01/12–24/01/16 | 24/01/17 | 3,126 sh2 trades | $0.70avg. | $2,188.2 | +0.7% | |
Joseph J. GalliganDirector | BioCorRxBICX | Open-market buy | 23/03/29 | 23/07/06 | 171,296 sh | $1.75 | $299,768 | +370.4% |
Louis C. LucidoDirector | BioCorRxBICX | Open-market buy | 23/04/03 | 23/04/05 | 171,296 sh | $1.75 | $299,768 | +163.2% |
BioCorRxBICX | Open-market buy | 23/01/30 | 23/01/31 | 400 sh2 trades | $1.39avg. | $554 | +0.4% | |
Louis C. LucidoDirector | BioCorRxBICX | Open-market buy | 23/01/26 | 23/01/27 | 500 sh | $1.29 | $645 | +0.5% |
Louis C. LucidoDirector | BioCorRxBICX | Open-market buy | 23/01/24 | 23/01/25 | 200 sh | $1.20 | $240 | +0.2% |
BioCorRxBICX | Open-market buy | 23/01/13 | 23/01/17 | 4,000 sh2 trades | $1.13avg. | $4,500 | +4.1% | |
BioCorRxBICX | Open-market buy | 22/12/30–23/01/03 | 23/01/04 | 2,315 sh3 trades | $1.09avg. | $2,514.45 | +2.4% |